The Company has developed a catheter lock solution containing generally recognized as safe (GRAS) ingredients. If approved, the Company's catheter lock solution could provide a safer alternative to heparin locks, the current standard of care. A PCT patent application, covering the product formulation and its intended use, has been submitted to the United States Patent and Trademark Office.